LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by date 2,440 pages found matching data breach- Businessman Suspects BP Oil Will Deny Claim
Jul-2-10 Houston, TX J.J., a partner in a company that supports deep water drilling, filed a claim against BP for small business loss of income on June 10 and finally got a call from BP's insurance adjuster yesterday. "Our claim is Loss of Income due to the moratorium, but now I find out that no permits have been issued for shallow water drilling either," s... - Study: Air Pollution Increases Risk of Stroke
Jun-30-10 Copenhagen, Denmark A new Danish study revealed that air pollution from car exhaust could trigger strokes in some people. The study showed that short-term exposure to certain air pollutants increased the admission rate for mild strokes in hospitals near Copenhagen, Denmark, according to Reuters. The team also noted that much more research needs to b... - Studies Link Proton Pump Inhibitors to Increased Fracture Risk
Jun-28-10 Philadelphia, PA Two recent studies have shown a link between osteoporosis proton pump inhibitors (PPIa), used for the treatment of heartburn. The US Food and Drug Administration has ordered the makers of the drugs to include a warning about PPI side effects, including over-the-counter PPIs. A 2008 study conducted by the University of Manitoba, in... - Avandia Rejected in Germany
Jun-27-10 Frankfurt, Germany Health insurers have been told to stop paying for Avandia , according to a 6/18/10 Reuters report. Meanwhile, the US Food and Drug Administration (FDA) prepares to hold an advisory conference concerning the risks associated with Avandia side effects. Germany's Federal Joint Committee of doctors and health insurers has recommended... - Potential Fosamax Class Action Lawsuit Emerging in Canada
Jun-21-10 Montreal, PQ Option-Consommateurs (OC), a not-for-profit consumer group based in Montreal, filed a class action demand in 2007 and according to the Canwest news service wants to launch a class action lawsuit against Merck Frosst for allegedly failing to disclose Fosamax side effects. A spokesperson for OC, Jacinthe Lauzon, cites a number of disturbi... - Antidepressants Linked to Miscarriage, Effexor Implicated
Jun-3-10 Montreal, PQ New research out of Canada is warning expectant moms that they run a far greater risk of losing their babies through miscarriage if they take antidepressants like Effexor during pregnancy. Researchers at the Universite de Montreal (UdeM) found that antidepressant use during pregnancy is associated with a 68 percent relative increase in... - Advocacy Group Re-States Petition to Ban Meridia, Blasts FDA
May-29-10 Washington, DC While various global health agencies have stepped up their opposition to Meridia sibutramine due to Meridia side effects, the consumer advocacy group Public Citizen (PC) has been railing against the diet drug since 2002. In March of that year, PC officially petitioned the US Food and Drug Administration (FDA) to ban the drug from pharmac... - FDA Warns of Increased Fracture Risk with Antacid Drugs
May-25-10 Washington, DC The FDA is warning of a possible increase in the risk for fractures of the hip, wrist, and spine if you take certain drugs for heartburn, acid reflux, or ulcers. The drugs belong to a class of medications called proton pump inhibitors (PPIs), which work by reducing the amount of acid in the stomach. They are available both as prescrip... - UK Health Authority Warns Expectant Mothers against Dangers of Antidepressant Use
May-21-10 London, UK Concern is mounting that the use of antidepressants such as Prozac by expectant mothers can increase the risk of persistent pulmonary hypertension (PPHN) for the infant. While the disorder is rare, the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK is advising doctors to carefully monitor expectant mothers who take drug... - More Concern about DePuy Metal-on-Metal Implants
May-14-10 London, UK Much has been written about DePuy Orthopedics and their potential for early failure due to an implied design flaw. Despite the fact that metal-on-metal hip implants are increasing in popularity and designed to last 15 years or so, early failures have prompted a recall of the DePuy hip replacement system known as the ASR cup. Since then the... - New Pampers Product Alleged to Cause Severe Skin Rash
May-12-10 Washington, DC The US Consumer Products Safety Commission (CPSC) is investigating various complaints that a new line of Pampers disposable diapers is causing severe, persistent diaper rashes and blisters resembling chemical burns. The makers of Pampers, Procter & Gamble (P&G), dispute the claims and continue to stand behind their product. A... - New Jersey Men Charged with Identity Theft
May-10-10 Freehold, NJ Identity theft fraud can occur even when a consumer performs a transaction in person, thanks to sophisticated systems that allow purveyors of identity theft scams to access accounts, passwords and other private information. The 5/6/10 edition of the Asbury Park Press details one of the most recent cases of identity theft and credit card fra... - What Is Bayer Really Saying About Yasmin / Yaz?
May-1-10 Washington, DC The US Food and Drug Administration (FDA) has negotiated with Yasmin and Yaz manufacturer Bayer HealthCare Pharmaceuticals to update the products labels for Yaz (3 mg drospirenone / 0.02 mg ethinyl estradiol) and Yasmin (3 mg drospirenone / 0.03 mg ethinyl estradiol) in the US in order to reflect concerns over the link between the oral c... - DePuy Hip Replacement Linked to Tumors
Apr-28-10 London, England Roughly 40,000 people who have received a DePuy hip replacement are set to have their implants reviewed by British health authorities over fears that the metal augmentations may be linked to non-cancerous tumors, severe swelling and sinew damage. The concerns arose from a string of growths that appeared in individuals who had undergo... - What's the Real Motivation Behind Medtronic Infuse Off-Label?
Apr-25-10 Washington, DC Off-label use of Medtronic bone graft was brought to the public's attention in 2008 when the US Food and Drug Administration (FDA) warned about Medtronic infuse bone graft use in association with the cervical spine. While doctors and surgeons have always enjoyed the authority and freedom to use drugs and medical devices off-label if they... - FDA Concerned About Infusion Pumps
Apr-24-10 New York, NY The US Food and Drug Administration (FDA) announced that it is requiring makers of infusion pumps to provide more test data before those pumps can be approved to go on the market. The announcement was made because of concerns about the safety of infusion pumps. According to The New York Times (04/24/10), the FDA has received reports o... - New Study Finds More Than 29,000 Cancers Caused by CT Scan Radiation
Apr-23-10 San Francisco, CA A new report suggests that CT scan radiation may be more dangerous than previously believed, as the medical procedure has been linked to at least 29,000 cases of cancer and 14,500 deaths in the US each year. Published in the Archives of Internal Medicine, the study drew data from the National Cancer Institute, which compared the am... - Paxil Off-Label Use to Be Focus of Heart Defects Trial
Apr-18-10 Washington, DC Paxil manufacturer GlaxoSmithKline (Glaxo) faces hundreds of Paxil lawsuits alleging that the antidepressant causes birth defects. Next up at the plate is Delaney Novak, a little girl born on April 4, 2002 with heart defects. In June, her parents Laura and Derek will contend that misconduct on the part of Glaxo over safety warnings for P... - Does Accutane Increase Risk of Blood Clots?
Apr-17-10 Seattle, WA Among the complications linked to anti-acne medication Accutane is increased risk of inflammatory bowel disease (IBD) and birth defects. Lawsuits have been filed against Accutane, now off the market, alleging that patients who took the medication were not warned of the risk of IBD. A recent study funded by the National Association for Co... - New Study Highlights Suicide Risk of Anticonvulsant Drugs
Apr-14-10 Boston, MA A study published this week in the Journal of the American Medical Association (JAMA) confirmed that taking anticonvulsants doubles the risk of suicidal thoughts and suicide attempts. The findings echo those emerging from a review two years ago by the US Food and Drug Administration (FDA). It should be noted that the risk is small, at less t...